Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32


Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors.

Payne AB, Miller CH, Ellingsen D, Driggers J, Boylan B, Bean CJ.

Haemophilia. 2019 Sep;25(5):e342-e344. doi: 10.1111/hae.13827. Epub 2019 Jul 29. No abstract available.


The Association Between Incentive Designs and Health Assessment or Biometric Screening Completion.

Heltemes KJ, Pelletier KR, Ippolito AC, Do DC, Boylan BC.

J Occup Environ Med. 2019 Apr;61(4):e146-e149. doi: 10.1097/JOM.0000000000001556.


Growth and adaptation of Zika virus in mammalian and mosquito cells.

Moser LA, Boylan BT, Moreira FR, Myers LJ, Svenson EL, Fedorova NB, Pickett BE, Bernard KA.

PLoS Negl Trop Dis. 2018 Nov 12;12(11):e0006880. doi: 10.1371/journal.pntd.0006880. eCollection 2018 Nov.


Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients.

Rampersad AG, Boylan B, Miller CH, Shapiro A.

Haemophilia. 2018 Sep;24(5):807-814. doi: 10.1111/hae.13565. Epub 2018 Jul 13.


Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen-Bethesda assay for factor VIII inhibitors.

Miller CH, Payne AB, Driggers J, Ellingsen D, Boylan B, Bean CJ.

Haemophilia. 2018 May;24(3):e116-e119. doi: 10.1111/hae.13434. Epub 2018 Mar 24. No abstract available.


Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.

Boylan B, Miller CH.

Haemophilia. 2018 May;24(3):487-491. doi: 10.1111/hae.13435. Epub 2018 Feb 20.


Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.

Miller CH, Boylan B, Shapiro AD, Lentz SR, Wicklund BM; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2017 Oct;15(10):1971-1976. doi: 10.1111/jth.13795. Epub 2017 Sep 14.


Mosquito cell-derived West Nile virus replicon particles mimic arbovirus inoculum and have reduced spread in mice.

Boylan BT, Moreira FR, Carlson TW, Bernard KA.

PLoS Negl Trop Dis. 2017 Feb 10;11(2):e0005394. doi: 10.1371/journal.pntd.0005394. eCollection 2017 Feb.


Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.

Boylan B, Rice AS, Neff AT, Manco-Johnson MJ, Kempton CL, Miller CH; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2016 Oct;14(10):1931-1940. doi: 10.1111/jth.13438. Epub 2016 Sep 17.


Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening.

Miller CH, Rice AS, Boylan B, Payne AB, Kelly FM, Escobar MA, Gill J, Leissinger C, Soucie JM; Hemophilia Inhibitor Research Study Investigators.

Am J Hematol. 2015 Oct;90(10):871-6. doi: 10.1002/ajh.24104. Epub 2015 Sep 10.


Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.

Boylan B, Rice AS, De Staercke C, Eyster ME, Yaish HM, Knoll CM, Bean CJ, Miller CH; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2015 Jun;13(6):1036-42. doi: 10.1111/jth.12902. Epub 2015 May 9.


Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasis.

Chamcheu JC, Pal HC, Siddiqui IA, Adhami VM, Ayehunie S, Boylan BT, Noubissi FK, Khan N, Syed DN, Elmets CA, Wood GS, Afaq F, Mukhtar H.

Skin Pharmacol Physiol. 2015;28(4):177-88. doi: 10.1159/000368445. Epub 2015 Jan 22.


Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.

Boylan B, Rice AS, Dunn AL, Tarantino MD, Brettler DB, Barrett JC, Miller CH; Hemophilia Inhibitor Research Study Investigators; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2015 Jan;13(1):47-53. doi: 10.1111/jth.12768. Epub 2014 Dec 11.


Linear sebaceous nevus syndrome associated with rod-cone dystrophy.

Lee S, Inglis H, Boylan B, Grigg J.

J Pediatr Ophthalmol Strabismus. 2014 Mar 4;51 Online:e13-5. doi: 10.3928/01913913-20140225-02.


Delphinidin, a dietary antioxidant, induces human epidermal keratinocyte differentiation but not apoptosis: studies in submerged and three-dimensional epidermal equivalent models.

Chamcheu JC, Afaq F, Syed DN, Siddiqui IA, Adhami VM, Khan N, Singh S, Boylan BT, Wood GS, Mukhtar H.

Exp Dermatol. 2013 May;22(5):342-8. doi: 10.1111/exd.12140.


Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study.

Miller CH, Rice AS, Boylan B, Shapiro AD, Lentz SR, Wicklund BM, Kelly FM, Soucie JM; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2013 Jul;11(7):1300-9. doi: 10.1111/jth.12259.


Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.

Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman DK, McKenzie SE, Cooley BC, Poncz M, Newman PJ.

Blood. 2013 Mar 7;121(10):1858-67. doi: 10.1182/blood-2012-07-443325. Epub 2012 Dec 20.


Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.

Gao C, Boylan B, Fang J, Wilcox DA, Newman DK, Newman PJ.

Blood. 2011 May 5;117(18):4946-52. doi: 10.1182/blood-2010-09-307751. Epub 2011 Mar 2.


Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia.

Bougie DW, Nayak D, Boylan B, Newman PJ, Aster RH.

Blood. 2010 Oct 21;116(16):3033-8. doi: 10.1182/blood-2010-03-277764. Epub 2010 Jun 29.


Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.

Gao C, Boylan B, Bougie D, Gill JC, Birenbaum J, Newman DK, Aster RH, Newman PJ.

J Clin Invest. 2009 Mar;119(3):504-11. doi: 10.1172/JCI36745. Epub 2009 Feb 9.


Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.

Bakchoul T, Boylan B, Sachs UJ, Bein G, Ruan C, Santoso S, Newman PJ.

Transfusion. 2009 Feb;49(2):265-70. doi: 10.1111/j.1537-2995.2008.01972.x. Epub 2008 Nov 4.


Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice.

Goel R, Schrank BR, Arora S, Boylan B, Fleming B, Miura H, Newman PJ, Molthen RC, Newman DK.

Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1996-2002. doi: 10.1161/ATVBAHA.108.172270. Epub 2008 Jul 31.


Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.

Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ.

Blood. 2008 Oct 1;112(7):2780-6. doi: 10.1182/blood-2008-02-142125. Epub 2008 Jul 18.


The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis.

Goel R, Boylan B, Gruman L, Newman PJ, North PE, Newman DK.

Am J Physiol Gastrointest Liver Physiol. 2007 Dec;293(6):G1205-14. Epub 2007 Oct 11.


Tests of the extension and deadbolt models of integrin activation.

Zhu J, Boylan B, Luo BH, Newman PJ, Springer TA.

J Biol Chem. 2007 Apr 20;282(16):11914-20. Epub 2007 Feb 13.


Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.

Boylan B, Chen H, Rathore V, Paddock C, Salacz M, Friedman KD, Curtis BR, Stapleton M, Newman DK, Kahn ML, Newman PJ.

Blood. 2004 Sep 1;104(5):1350-5. Epub 2004 May 18.


Inactivation of ompR promotes precocious swarming and flhDC expression in Xenorhabdus nematophila.

Kim DJ, Boylan B, George N, Forst S.

J Bacteriol. 2003 Sep;185(17):5290-4.


Characterization of the pleiotropic phenotype of an ompR strain of Xenorhabdus nematophila.

Forst S, Boylan B.

Antonie Van Leeuwenhoek. 2002 Aug;81(1-4):43-9.


Comment on computer article.

Boylan BJ.

Am J Orthod Dentofacial Orthop. 1993 Dec;104(6):23A. No abstract available.


Mushroom spring for minor tooth movement.

Boylan BJ, Sheridan JJ.

J Clin Orthod. 1993 Sep;27(9):483-4. No abstract available.


Supplemental Content

Loading ...
Support Center